{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:45:18Z","timestamp":1790459118638,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T00:00:00Z","timestamp":1547942400000},"content-version":"vor","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88881.068093\/2014-01"],"award-info":[{"award-number":["88881.068093\/2014-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["305560\/2013-1"],"award-info":[{"award-number":["305560\/2013-1"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejphar.2018.01.019","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T02:43:45Z","timestamp":1517366625000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Phosphodiesterase-3 inhibitor cilostazol reverses endothelial dysfunction with ageing in rat mesenteric resistance arteries"],"prefix":"10.1016","volume":"822","author":[{"given":"Hicla S.","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge\u00f3rgia A.","family":"Lima-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Santos-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Gomes-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria P.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano E.","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.01.019_bib1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1213\/ANE.0b013e3182147e3c","article-title":"Review article: implications of vascular aging","volume":"112","author":"Barodka","year":"2011","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2018.01.019_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cardiores.2004.12.027","article-title":"Endothelial aging","volume":"66","author":"Brandes","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2018.01.019_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.019_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphys.2012.00132","article-title":"Mechanisms involved in the aging-induced vascular dysfunction","volume":"3","author":"El Assar","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20090096","article-title":"EDHF: an update","volume":"117","author":"F\u00e9l\u00e9tou","year":"2009","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2018.01.019_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/jscd.2000.7216","article-title":"Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction","volume":"9","author":"Gotoh","year":"2000","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2018.01.019_bib7","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1073\/pnas.092089799","article-title":"cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions","volume":"99","author":"Griffith","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.01.019_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2006.01.022","article-title":"Activation of endothelial nitric oxide synthase by cilostazol via a cAMP\/protein kinase A- and phosphatidylinositol 3-kinase\/Akt-dependent mechanism","volume":"189","author":"Hashimoto","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2018.01.019_bib9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/meta.2002.35191","article-title":"Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus","volume":"51","author":"Ikewaki","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2018.01.019_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1476-5381.1988.tb11535.x","article-title":"Impairment of endothelium-dependent relaxation: an early marker for atherosclerosis in the r rabbit","volume":"94","author":"Jayakody","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib11","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2174\/1381612033453910","article-title":"Cilostazol as a unique antithrombotic agent","volume":"9","author":"Kambayashi","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2018.01.019_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.300.2.709","article-title":"Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells","volume":"300","author":"Kim","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.01.019_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.HYP.0000158263.64320.eb","article-title":"Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F","volume":"45","author":"Kim","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2018.01.019_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0022-3565(24)34971-7","article-title":"Heterogeneity of endothelium-dependent vasodilation in pressurized cerebral and small mesenteric resistance arteries of the rat","volume":"290","author":"Lagaud","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.01.019_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.CIR.0000048892.83521.58","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a \u201cset up\u201d for vascular disease","volume":"107","author":"Lakatta","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.019_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1124\/jpet.104.079780","article-title":"Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol","volume":"313","author":"Lee","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.01.019_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vph.2015.01.002","article-title":"Cilostazol induces vasodilation through the activation of Ca(2+)-activated K(+) channels in aortic smooth muscle","volume":"70","author":"Li","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jvs.2008.02.062","article-title":"Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions","volume":"48","author":"Lida","year":"2008","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ejphar.2018.01.019_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1152\/ajpcell.1990.258.3.C399","article-title":"cGMP-dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells","volume":"258","author":"Lincoln","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib20","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/j.1523-1755.2005.00671.x","article-title":"Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging","volume":"68","author":"Long","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2018.01.019_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.04.006","article-title":"Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats","volume":"538","author":"Matsumoto","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib22","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1152\/ajpheart.00303.2005","article-title":"Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats","volume":"289","author":"Matsumoto","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2008.10.006","article-title":"Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpolarizing factor response in mesenteric arteries from Type 2 diabetic rats","volume":"599","author":"Matsumoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.vph.2006.10.019","article-title":"Vascular endothelium summary statement II: cardiovascular disease prevention and control","volume":"46","author":"Mensah","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.01.019_bib26","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/ATVBAHA.108.164368","article-title":"Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells","volume":"28","author":"Ota","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(01)00431-2","article-title":"Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence","volume":"158","author":"Otsuki","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2018.01.019_bib28","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1161\/STROKEAHA.110.609834","article-title":"Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats","volume":"42","author":"Oyama","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2018.01.019_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lfs.2005.02.036","article-title":"Inhibition of acetylcholine-induced EDHF response by elevated glucose in rat mesenteric artery","volume":"78","author":"Ozkan","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2018.01.019_bib30","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/j.1476-5381.2012.01945.x","article-title":"Effect of age and COX-2-derived prostanoids on the progression of adult vascular dysfunction in the offspring of diabetic rats","volume":"166","author":"Ramos-Alves","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1474-9726.2009.00466.x","article-title":"Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation","volume":"8","author":"Rodriguez-Ma\u00f1as","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2018.01.019_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/hr.2009.211","article-title":"Vasculoprotective effect of cilostazol in aldosterone-induced hypertensive rats","volume":"33","author":"Sakurada","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2018.01.019_bib33","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.0000117403.64398.53","article-title":"Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol","volume":"109","author":"Shin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.019_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ajh.2008.6","article-title":"Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes","volume":"21","author":"Suzuki","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2018.01.019_bib35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1567202611666140912113152","article-title":"The phosphodiesterase III inhibitor cilostazol ameliorates ethanol-induced endothelial dysfunction","volume":"11","author":"Takagi","year":"2014","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.ejphar.2018.01.019_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pharmthera.2011.10.004","article-title":"Age-related changes in endothelial function and blood flow regulation","volume":"133","author":"Toda","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2018.01.019_bib37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1139\/y2012-073","article-title":"The endothelium: influencing vascular smooth muscle in many ways","volume":"90","author":"Triggle","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib38","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/bjp.2008.200","article-title":"Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin","volume":"154","author":"Xavier","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.019_bib39","doi-asserted-by":"crossref","first-page":"e100356","DOI":"10.1371\/journal.pone.0100356","article-title":"Tranilast increases vasodilator response to acetylcholine in rat mesenteric resistance arteries through increased EDHF participation","volume":"9","author":"Xavier","year":"2014","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:14:21Z","timestamp":1751260461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":39,"alternative-id":["S0014299918300268"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase-3 inhibitor cilostazol reverses endothelial dysfunction with ageing in rat mesenteric resistance arteries","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}